Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. Features

The latest weapon in the fight against Alzheimer’s? Flickering lights

Add as a preferred source on Google
Image used with permission by copyright holder

Alzheimer’s is a lot of things, but it’s most notable for what it’s not. It’s a neurodegenerative disease which affects an estimated 5.5 million people in the United States alone. It’s a debilitating, life-changing disorder that’s intensely cruel in its effects, both to the immediate sufferer and their loved ones. It destroys almost one-third of a brain’s mass, gouging out enormous ravines while piling up heaps of junk amyloid plaques between the neurons. It is not curable.

At least, not yet.

Image used with permission by copyright holder

While treatments exist in the form of medication, currently these are capable only of slowing the speed of inevitable, terrible decline. To get this out of the way up top: No, researchers have not yet found a miracle treatment that can stop or, as would be the dream, reverse the onset and progression of Alzheimer’s. But investigators at Georgia Institute of Technology and Emory University have discovered a new a promising — and, by their own admission, distinctly “science fiction” sounding — treatment approach which could one day lead to such a thing.

Recommended Videos

In lab tests, they have discovered that flickering light pulsed at a very specific gamma frequency, at 40 beats per second, causes brains to release signaling chemicals which can help fight the disease. One of these signaling chemicals activates a type of brain cell called microglia. These specialized cells are the primary immune defense in the brain, acting like trash collectors by clearing out pathogens like amyloid plaque. However, Alzheimer’s stops them working as they should. This proposed treatment could help kick it back into action.

Alzheimers researcher wearing glasses
Image used with permission by copyright holder

“We engineered the brain’s immune signaling with simple flickering lights, like a strobe light but much faster,” Annabelle Singer, an assistant professor of biomedical engineering at Georgia Tech and Emory, told Digital Trends. “We’ve known for a long time that flickering lights entrain neural electrical activity at the same frequency in visual brain areas. But we did not know that this would trigger immune signaling. Interestingly, different frequencies of light flicker produce different patterns of immune signals. We think understanding the relationship between different types of sensory stimulation and its effects on immune function will be key to developing different therapeutic applications.”

Restarting the brain’s immune system

The researchers experienced their first breakthrough in 2016. That year, they used a relatively new technique called optogenetics to simulate the brains of mice. Optogenetics is a treatment in which light-sensitive genetic code can be added to neurons to make them individually controllable. Using this technique, the researchers were able to demonstrate that light flickered at a gamma frequency helped mobilize microglia in mice engineered to develop amyloid plaques. They did this because they found that mice with amyloid plaques experienced a deficit of gamma electrical activity in the part of the brain required for forming memories.

In their latest work, published this month in the Journal of Neuroscience, they have further demonstrated that similar treatment also prompts a surge of additional small proteins which signal to other cells. The strobe lights, in other words, sound the alarm which stirs an otherwise dormant immune response into action.

Image used with permission by copyright holder

“We were very excited to find that visual stimulation triggers changes in immune signaling in about 15 minutes in the brain,” said Levi Wood, assistant professor in Georgia Tech School of Mechanical Engineering. “[This] is much faster than you would typically see by giving a drug, which takes hours to have an effect. Interestingly, we also found that the signaling we induce in the brain is both rapid and decays quickly. We think that the dynamics of this activity has the potential to produce beneficial effects by stimulating an immune response for an appropriate period of time to — for example — clear Alzheimer’s plaques without causing chronic neuroinflammation.”

More esoteric mind expansion practices have promoted gamma waves for years in the form of light and sound meditation for enhancing mindfulness and focus. But the work of researchers including Singer and Wood connects gamma to working memory.

Alzheimers research flashing lights
Image used with permission by copyright holder

“Finding that gamma electrical activity affects immune cells and immune function in the brain was a big surprise,” said Singer. “Brain immune function and interactions between neurons and immune function are thought to play a major role in many diseases. Understanding these interactions and how to control them could have broad impacts.”

Human trials are underway

At present, the researchers are carrying out a small trial of their pulsed light technique with human Alzheimer’s patients. This is being carried in collaboration with the Emory Brain Health Center, one of the world’s leading brain research centers. Unlike the 2016 mouse research, this study is carried out entirely using non-invasive stimulation. Patients are shown the pulsed light using special glasses. While Singer and Wood don’t have results to announce just yet, these will be revealed in the coming months.

“Data collection from this initial clinical test is wrapping up and we are analyzing and examining the results,” Singer said. “So far, patients report good safety and tolerance of the treatment. We will know more about the effects in the coming months. We are also doing many more studies in animal models to understand how neural activity alters immune function in healthy animals and in disease models.”

Alzheimers researcher
Image used with permission by copyright holder

As with any medical research, it’s crucial that in-depth studies are carried out before this treatment proceeds further towards the market. There are also, needless to say, significant differences between mice and humans; meaning that what works in one model may not necessarily translate to the other. But the potential upside is enormous. It could also potentially help treat brain immune dysfunction in other conditions such as traumatic brain injury, depression, and schizophrenia.

“The idea that you could use an entirely non-invasive method to change how the brain’s immune system works, to potentially to move it back toward a healthy state in these diseases, would be revolutionary,” Levi said. “The mechanism relating sensory stimulation to brain immune function is a very interesting puzzle.”

Hopefully it is one that they are able to piece together.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Anthropic’s sensitive internal data was exposed, and AI helped make it happen
Even the company behind Claude isn't immune to AI-powered security threats, as researchers discovered some worrying vulnerabilities.
Claude Anthropic Featured

AI companies spend enormous amounts of time convincing us their technology is safe and secure. But what happens when those same companies become targets of increasingly sophisticated AI-powered attacks? Anthropic, the company behind Claude, is now facing that question. According to a Washington Post report, cybersecurity startup Cathedral discovered vulnerabilities that let its researchers access sensitive information in Anthropic's internal systems.

The researchers used AI agents to identify potential entry points in less than 12 hours. Interestingly, they didn't need to crack Claude itself. Instead, they exploited weaknesses in third-party business applications that Anthropic uses for everyday operations. Anthropic's security testing program disclosed the findings, which allows outside researchers to identify and report vulnerabilities.

Read more
A new startup wants to fix the military’s working-dog shortage with cloning and gene editing
Promising pitch, plenty of unanswered questions about the dogs.
a new startup wants to fix the militarys working dog shortage with cloning and gene editing warhound featured image

Military working dogs charge into places the rest of us would flee. So, I understand why anyone would want to breed tougher, healthier dogs for the job.

Warhound, a new startup from Colossal Biosciences co-founder Ben Lamm and Anduril co-founder Palmer Luckey, has stepped out of stealth with $200 million to clone and gene-edit working dogs for American troops, police departments, and emergency services (via TechCrunch).

Read more
AI can describe a picture, but it still struggles to understand blind users
A University of Maryland study finds that Be My AI often buries useful answers in lengthy descriptions, leaving blind users to work harder to get the information they need.
Blind Man using walking stick

AI can describe a picture, identify objects, and answer questions about what a camera sees. But when a blind user needs a quick answer, getting an entire spoken essay about the scene isn't exactly helpful. Researchers at the University of Maryland (UMD) have found that AI-powered visual assistance can leave blind users doing too much work to get the information they actually need.

The study, titled Say It My Way: Exploring Control in Conversational Visual Question Answering with Blind Users, examined how people interact with Be My AI, an AI-powered feature of the Be My Eyes app. The researchers found that users often received lengthy descriptions that didn't adequately address their immediate goals, forcing them to ask follow-up questions or find ways to steer the AI towards a more useful answer.

Read more